Updated:
Altaris
Altaris is an investment firm with an exclusive focus on acquiring and building companies in the healthcare industry. Since inception, Altaris has invested in...
Altaris
Altaris is an investment firm with an exclusive focus on acquiring and building companies in the healthcare industry. Since inception, Altaris has invested in more than 50 companies across a range of healthcare subsectors, with a consistent goal of delivering value to the healthcare system and generating attractive financial returns for investors.
General information
Firm type
Private Equity
Year founded
2003
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, United States
Principals
George Aitken-Davies
Co-Founder
Daniel Tully
Co-Founder
Aaron Bell
Portfolio Engagement
Lana Dweik
Capital Markets
Matteo Foderaro
Pharmaceuticals and Life Sciences
Nicholas Fulco
Tech-Enabled Services
Mike Grippo
Portfolio Engagement
Brendan McGrath
Medical Devices & Diagnostics
Charles Mullens
CFO and COO
Garikai Nyaruwata
Pharmaceuticals and Life Sciences
Justin Tayabji
Tech-Enabled Services
Iain Baird
Operating Partner
Ger Brophy
Operating Partner
Tim Callahan
Operating Partner
Shawn Cavanagh
Operating Partner
Bernard Lyons
Operating Partner
Greg Sargen
Operating Partner
Rafael Torres
Operating Partner
Sector focus
Frequently asked questions
What asset classes does Altaris target?
Available records list buyouts, co-investments, complex situations, divestitures, growth equity, recapitalisations and spin-offs.
Does Altaris publish AUM or deployment figures?
No AUM or deployment numbers are disclosed in the source material.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: